|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005682,
umls-concept:C0087111,
umls-concept:C0439230,
umls-concept:C0681850,
umls-concept:C0681906,
umls-concept:C0878773,
umls-concept:C1280500,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2343853,
umls-concept:C2349001,
umls-concept:C2697811
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-4-15
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To assess the onset of efficacy of fesoterodine 4 mg versus placebo in subjects with overactive bladder (OAB) symptoms.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1059-65
|
|
pubmed:meshHeading |
pubmed-meshheading:21428726-Adult,
pubmed-meshheading:21428726-Aged,
pubmed-meshheading:21428726-Aged, 80 and over,
pubmed-meshheading:21428726-Benzhydryl Compounds,
pubmed-meshheading:21428726-Double-Blind Method,
pubmed-meshheading:21428726-Female,
pubmed-meshheading:21428726-Humans,
pubmed-meshheading:21428726-Male,
pubmed-meshheading:21428726-Middle Aged,
pubmed-meshheading:21428726-Time Factors,
pubmed-meshheading:21428726-Urinary Bladder,
pubmed-meshheading:21428726-Urinary Bladder, Overactive,
pubmed-meshheading:21428726-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Effect of fesoterodine 4 mg on bladder diary and patient-reported outcomes during the first week of treatment in subjects with overactive bladder.
|
|
pubmed:affiliation |
Department of Urology, Jewish General Hospital, Montreal, QC, Canada. jcorcos@jgh.mcgill.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
